Skip to main content
. 2019 Mar 25;12(1):6–13. doi: 10.3400/avd.ra.18-00163

Table 1 Early outcomes: EVAR-1, DREAM versus our study.

Outcome (0–6 months) EVAR-1 (n=626) DREAM (n=173) Our study (n=596)
Aneurysm related-mortality 14 (2.2%) 3 (3.5%) 6 (1.0%)
  Rupture before EVAR 5 0 4
  Rupture after EVAR 7 0 0
  Other 2 3 2
Reinterventions 67 (10.7%) 14 (16.5%) 11 (1.8%)